Thomas  Jagoe

Assistant Professor

Oncology; Medicine

Address:
Jewish General Hospital
Segal Cancer Centre
3755 Cote Ste-Catherine Road
Montreal, QC H3T 1E2

Telephone: (514) 340 - 8222 x 4205
E-mail: thomas.jagoe@mcgill.ca

Education: PhD Newcastle-upon-Tyne UK; MB BChir Cambridge University and St Mary's Hospital Medical School, London; BA Cambridge

Clinical Focus: Nutrition and exercise rehabilitation in Cancer Cachexia; Pulmonary Medicine

Research Focus: Effects of chemotherapy on muscle; Maintaining muscle exercise function in hypoxia; Practical advances in clinical care of patients with cancer cachexia


Recent Presentations:

Treatment planning in cancer cachexia: outcomes and objectives. University of Alberta, Faculty of Agriculture, Life and Environmental Sciences, Metabolic and Cardiovascular Diseases Laboratory Seminars. Cross Cancer Institute, Edmonton June 23th 2011.


Recent Publications:

Wing, S.S., S.H. Lecker, R.T. Jagoe.
Proteolysis in illness-associated skeletal muscle atrophy: from pathways to networks.
Crit Rev Clin Lab Sci 2011 1-22

Archer-Lahlou, E., Lan, C., R.T. Jagoe.
Environmental conditions in muscle tissue culture alter responses to atrophy signals.
J Cachexia Sarcopenia Muscle 2011 2: 209 #1-03

Wing, S., Vanderbyl, BL, Van der Borch C., Murphy, R., Grunbaum, A., MacNamara, E., Atherton, J., Baracos, V., Mazurak, V., R.T. Jagoe
Serum IGF-1 levels help detect and predict skeletal muscle loss in cancer patients.
J Cachexia Sarcopenia Muscle
2011 2: 227 #3-12.